All Stories

  1. In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend
  2. A step-by-step protocol based on data mining to explore purinergic signaling in glioblastoma
  3. Retinoic acid-induced alterations enhance eATP-mediated anti-cancer effects in glioma cells: Implications for P2X7 receptor variants as key players
  4. In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe
  5. P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: role of the A2A/CD39/CD73 axis
  6. P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior
  7. P2X7 Variants in Pathophysiology
  8. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation
  9. Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting report
  10. The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia
  11. Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
  12. Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells
  13. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
  14. EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report
  15. P2X7-dependent exchange of extracellular microparticles and mitochondria by mouse microglia
  16. Emerging roles of purinergic signaling in anti-cancer therapy resistance
  17. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
  18. A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
  19. A2A Receptor contributes to tumor progression in P2X7 null mice
  20. Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
  21. Administration of P2X7 Receptor Blockers in Oncological Experimental Models
  22. Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation
  23. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  24. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
  25. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
  26. Astrocytes‐derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein
  27. Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics
  28. The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia
  29. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  30. Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  31. Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
  32. P2X7 Receptor in Hematological Malignancies
  33. P2X7 Variants in Oncogenesis
  34. Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression
  35. Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  36. Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
  37. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
  38. The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility
  39. Detection of Extracellular ATP in the Tumor Microenvironment, Using the pmeLUC Biosensor
  40. Role of the P2X7 receptor in tumor-associated inflammation
  41. Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
  42. Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue
  43. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
  44. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells
  45. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
  46. Emerging Roles of Purinergic Signaling in Diabetes
  47. Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
  48. The P2X7 receptor: A main player in inflammation
  49. ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
  50. P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses.
  51. Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells
  52. P2 receptors in cancer progression and metastatic spreading
  53. Extracellular purines, purinergic receptors and tumor growth
  54. new insights on the therapeutic potential of P2X7 antagonists in human pathology
  55. Emerging Roles of P2X Receptors in Cancer
  56. Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)
  57. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
  58. Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
  59. Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
  60. P2X receptors: New players in cancer pain
  61. New intriguing roles of ATP and its receptors in promoting tumor metastasis
  62. Purinergic Signaling in Bone
  63. The P2X7 receptor is a key modulator of aerobic glycolysis
  64. First in vivo demonstration that P2X7 receptor is an oncogene
  65. role of P2X7 receptor in bone cancer and bone metastasis
  66. Purinergic signaling in giant cell formation
  67. The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation
  68. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
  69. cAMP efflux from human trophoblast cell lines: a role for multidrug resistance protein (MRP)1 transporter
  70. P2X7: a growth-promoting receptor—implications for cancer
  71. Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis
  72. Somatostatin as a Regulator of First-Trimester Human Trophoblast Functions
  73. The P2X7 receptor: a key player in IL-1 processing and release
  74. Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes
  75. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles
  76. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration
  77. Stimulation of P2 receptors causes release of IL-1β–loaded microvesicles from human dendritic cells
  78. Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells
  79. The P2X7 Receptor: A Key Player in IL-1 Processing and Release
  80. P2X7 receptor: Death or life?
  81. Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors
  82. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential, Increases Cellular ATP Levels, and Promotes Serum-independent Growth
  83. The Antibiotic Polymyxin B Modulates P2X7 Receptor Function
  84. Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients: A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes
  85. Tyrosine Phosphorylation of HSP90 within the P2X7 Receptor Complex Negatively Regulates P2X7 Receptors
  86. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
  87. Human Leukocyte Antigen-A,-B,-C and -DR Alleles and Soluble Human Leukocyte Antigen Class I Serum Level in Ménière's Disease
  88. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor
  89. Homology modeling and active-site residues probing of the thermophilicAlicyclobacillus acidocaldariusesterase 2
  90. Overexpression and properties of a new thermophilic and thermostable esterase from Bacillus acidocaldarius with sequence similarity to hormone-sensitive lipase subfamily